Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.27B |
| Enterprise Value | 5.26B |
| P/E Ratio | 83.84 |
| PEG Ratio | -1.21 |
| Price/Sales Ratio | 2.79 |
| Price/Book Ratio | 1.05 |
| Enterprise/Revenue | 2.71 |
| Enterprise/EBITDA | 19.04 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | -0 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 1.73B |
| Revenue/Share | 1.39 |
| Gross Profit | 563.3M |
| EBITDA | 312.47M |
| Net Income | 77M |
| Diluted EPS | 0.06 |
Balance Sheet
| Total Cash | 899.88M |
| Total Cash/Share | 0.76 |
| Total Debt | 696.48M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 2.23 |
| Book Value Per Share | 3.7 |
Price History
| 52-Week Change | -10.98 |
| 52-Week High | 5 |
| 52-Week Low | 3.24 |
| Moving Average 50 Days | 3.87 |
| Moving Average 200 Days | 4.06 |
Statistics
| Average Volume | 19.8M |
| Shares Outstanding | 1.19B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.07 |
| Trailing Annual Dividend Yield | 1.8 |
| Payout Ratio | 2.52 |
| Last Split Factor | 3:1 |
| Last Split Date | May 10, 2017 |
AD
